Biotechnology Policies and Innovation Support Infrastructure in the Context of Pharmaceuticals

Jeremy Howells and Ian Neary
Additional contact information
Jeremy Howells: The Judge Institute for Management Studies/ESRC Centre for Business Research University of Cambridge
Ian Neary: University of Essex Colchester

Chapter 7 in Intervention and Technological Innovation, 1995, pp 195-232 from Palgrave Macmillan

Abstract: Abstract The use of biological processes by man dates back thousands of years to the discovery of brewing, baking and cheesemaking. It was only in the last century that significant advances were made in the understanding of these and similar biological processes. The industrial applications of some of these developments were realised at the turn of the century, with the fermentative production of commodity chemicals, such as butanol and acetone, and the establishment of industries producing such substances as antibiotics, amino acids and enzymes in the postwar period. However, it is only since 1953, when the structure of DNA was discovered, and more especially since the early 1970s with the development of powerful new techniques – notably, recombinant DNA technology (genetic engineering) and hybridoma technology (leading to the production of monoclonal antibodies) – that biotechnology has attracted public interest and that its commercial potential has been fully appreciated. There is now little disagreement that biotechnology is one of the two or three most significant technologies in terms of commercial promise in the period up to the end of the century.

Keywords: Innovation Support; Biotechnology Programme; Biotechnology Policy; Private Sector Support; Research Club (search for similar items in EconPapers)
Date: 1995
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:palchp:978-0-230-37916-9_7

Ordering information: This item can be ordered from
http://www.palgrave.com/9780230379169

DOI: 10.1057/9780230379169_7

Access Statistics for this chapter

More chapters in Palgrave Macmillan Books from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().